Advertisement
Screener

LEXARIA BIOSCIENCE CORP. (LEXX) EBITDA

LEXARIA BIOSCIENCE CORP. (LEXX) EBITDA

  • 2026-05-31: Basis Reported; EBITDA -$1.98M*; Operating income -$1.99M; Depreciation and amortization $13.91K*.
  • 2026-02-28: Basis Reported; EBITDA -$1.44M*; Operating income -$1.45M; Depreciation and amortization $14.01K*.
  • 2025-11-30: Basis Reported; EBITDA -$1.56M; Operating income (m); Depreciation and amortization (m).
  • 2025-08-31: Basis Reported; EBITDA -$2.68M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2024-08-31 to 2025-11-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-05-31Reported-$1.98M*-$1.99M$13.91K*(m)(m)$0.00*-$1.64M*$0.00$970.83K(m)$14.00
2026-02-28Reported-$1.44M*-$1.45M$14.01K*(m)(m)$40.82K*-$2.16M*$0.00$475.39K(m)$2.60K
2025-11-30Reported-$1.56M(m)(m)(m)(m)$0.00-$984.10K$0.00$671.34K(m)$1.79K
2025-08-31Reported-$2.68M(m)(m)(m)-1538.27%(m)(m)(m)(m)(m)(m)
2025-05-31Reported-$3.73M*-$3.75M$21.75K*(m)(m)-$1.00*-$3.58M*$0.00$2.72M(m)$0.00
2025-02-28Reported-$2.74M*-$2.75M$8.73K*(m)(m)$1.00*-$1.50M*$0.00$1.69M(m)$0.00
2024-11-30Reported-$2.68M(m)(m)(m)-1458.20%$24.64K-$2.73M$2.72K$1.95M(m)$0.00
2024-05-31Reported(m)-$1.74M(m)$84.00K*(m)$0.00*-$1.27M*$0.00$573.09K(m)(m)
2024-02-29Reported(m)-$668.00K(m)$145.00K*(m)$0.00*-$619.61K*$0.00$245.78K(m)(m)
2023-11-30Reported(m)-$1.14M(m)$151.28K(m)$0.00-$1.18M$4.82K$574.49K(m)(m)
2023-05-31Reported(m)-$2.40M(m)$77.71K*(m)$0.00*-$1.79M*$12.75K$1.64M(m)(m)
2023-02-28Reported(m)-$1.32M(m)$20.02K*(m)$13.25K*-$1.23M*$2.96K$696.18K(m)(m)
2022-11-30Reported(m)-$1.70M(m)$97.73K(m)$20.50K-$1.25M$15.79K$829.49K(m)(m)
2022-05-31Reported(m)-$2.42M(m)$99.72K*(m)$6.81K*-$1.26M*$18.64K$752.10K(m)(m)
2021-05-31Reported(m)-$2.57M(m)$204.06K(m)(m)-$1.16M*$59.99K$454.44K(m)(m)
2017-11-30Reported(m)-$578.71K(m)$24.64K(m)(m)-$520.32K$6.10K$110.39K(m)(m)
2016-11-30Reported(m)-$400.55K(m)(m)(m)$0.00-$100.99K(m)$7.26K(m)(m)
2016-05-31Reported(m)-$264.20K(m)(m)(m)(m)(m)(m)$158.00(m)(m)
2016-02-29Reported(m)-$274.56K(m)(m)(m)(m)(m)(m)$6.85K(m)(m)
2015-11-30Reported(m)-$411.74K(m)(m)(m)$3.09K-$208.95K(m)$1.98K(m)(m)
2015-05-31Reported(m)-$511.01K(m)(m)(m)(m)(m)(m)$107.00(m)(m)
2015-02-28Reported(m)-$458.61K(m)(m)(m)(m)(m)(m)$240.00(m)(m)
2014-11-30Reported(m)-$398.07K(m)(m)(m)$0.00-$173.21K(m)$48.04K(m)(m)
2014-07-31Reported(m)-$567.95K(m)(m)(m)(m)-$222.88K*(m)(m)(m)(m)
2013-07-31Reported(m)-$57.67K(m)(m)(m)(m)$60.27K*(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-08-31Reported-$11.83M(m)(m)(m)-1675.75%$24.65K-$10.45M$2.72K$8.24M(m)(m)
2024-08-31Reported-$5.71M(m)(m)(m)-1230.01%$43.01K-$4.96M$4.82K$2.36M(m)(m)
2023-08-31Reported(m)-$6.53M(m)$226.21K(m)$33.75K-$5.88M$31.50K$3.67M(m)(m)
2022-08-31Reported(m)-$6.62M(m)$255.40K(m)$49.19K-$4.88M$71.84K$1.84M(m)$0.00
2021-08-31Reported(m)-$5.69M(m)$722.74K(m)(m)-$3.99M$175.35K$1.26M(m)$6.09K
2016-08-31Reported(m)-$1.28M(m)(m)(m)$3.09K-$660.86K$45.62K$9.02K(m)$0.00
2015-08-31Reported(m)-$1.98M(m)(m)(m)$0.00-$1.50M(m)$146.47K(m)(m)
2014-08-31Reported(m)-$1.56M(m)(m)(m)(m)-$515.82K(m)$0.00(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30